The second Department of management of listed companies of Shenzhen Stock Exchange issued a letter of concern to Galaxy Biomedical Investment Co.Ltd(000806) on December 29. In order to solve the problem of fund occupation of Galaxy Group, the company’s controlling shareholder Galaxy Group and the company intend to offset the debt of galaxy group to the company of 29.01 million yuan due to non operating fund occupation with 1073 yuan of the creditor’s right of zhongfangxin to the company and the creditor’s right of Tiandi Heming to the company of 1.6811 million yuan. Shenzhen stock exchange requires the company to explain the reason and rationality of using creditor’s rights and debts instead of cash compensation; Explain whether the credit and debt repayment agreement signed this time has been approved by the supplier in advance and whether there are unresolved disputes.
(interface News)
